Successful Use of Recombinant Activated Factor VII for Postoperative Hemorrhage
Author Information
Author(s): Vlachos Konstantinos, Archontovasilis Fotis, Papadima Artemisia, Maragiannis Dimitrios, Aloizos Stavros, Lagoudianakis Emmanuel, Dalianoudis Ioannis G, Koronakis Nikolaos, Chrysikos John, Zaravinos Spyros, Manouras Andreas
Primary Institution: 401 General Army Hospital of Athens, Athens, Greece
Hypothesis
Can recombinant activated factor VII (rFVIIa) effectively control life-threatening bleeding in trauma patients?
Conclusion
The use of rFVIIa appears to be effective in managing severe bleeding in trauma patients when standard treatments fail.
Supporting Evidence
- The patient experienced critical hemorrhage after renal biopsy.
- Standard transfusion therapy was unsuccessful before administering rFVIIa.
- rFVIIa led to immediate cessation of bleeding and stabilization of the patient's condition.
Takeaway
Doctors used a special medicine called rFVIIa to help a very sick man stop bleeding after surgery, and it worked well.
Methodology
The patient received rFVIIa after standard treatments failed to control bleeding.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
A 65-year-old Greek man with no pre-existing coagulopathy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website